Literature DB >> 22273233

Klatskin tumors and the accuracy of the Bismuth-Corlette classification.

Andreas Paul1, Gernot M Kaiser, Ernesto P Molmenti, Tobias Schroeder, Spiridon Vernadakis, Arzu Oezcelik, Hideo A Baba, Vito R Cicinnati, Georgios C Sotiropoulos.   

Abstract

The Bismuth-Corlette (BC) classification is the current preoperative standard to assess hilar cholangiocarcinomas (HC). The aim of this study is to evaluate the accuracy, sensitivity, and prognostic value of the BC classification. Data of patients undergoing resection for HC were analyzed. Endoscopic retrograde cholangiography and standard computed tomography were undertaken in all cases. Additional 3D-CT-reconstructions, magnetic resonance imaging, and percutaneous transhepatic cholangiography were obtained in selected patients. A systematic review and meta-analysis of the literature was performed. Ninety patients underwent resection of the hilar bile duct confluence, with right or left hemihepatectomy in 68 instances. The overall accuracy of the BC classification was 48 per cent. Rates of BC under- and over-estimation were 29 per cent and 23 per cent, respectively. The addition of MRI, 3D-CT-reconstructions, or percutaneous transhepatic cholangiography improved the accuracy to 49 per cent (P = 1.0), 53 per cent (P = 0.074), and 64 per cent (P < 0.001), respectively. Lowest sensitivity rates were for BC Type IIIA/IIIB tumors. Meta-analysis of published BC data corresponding to 540 patients did not reach significance. The BC classification has low accuracy and no prognostic value in cases of HC undergoing resection.

Entities:  

Mesh:

Year:  2011        PMID: 22273233

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  13 in total

1.  A simple system to predict perihilar cholangiocarcinoma resectability.

Authors:  Karim Boudjema; Laurent Sulpice; Sylvain Garnier; Jean-François Bretagne; Yves Gandon; Tanguy Rohou
Journal:  J Gastrointest Surg       Date:  2013-05-09       Impact factor: 3.452

Review 2.  Multimodal treatment strategies for advanced hilar cholangiocarcinoma.

Authors:  Matthew J Weiss; David Cosgrove; Joseph M Herman; Neda Rastegar; Ihab Kamel; Timothy M Pawlik
Journal:  Langenbecks Arch Surg       Date:  2014-06-25       Impact factor: 3.445

3.  One-stage resection for Bismuth type IV hilar cholangiocarcinoma with high hilar resection and parenchyma-preserving strategies: a cohort study.

Authors:  Jing Wang Tan; Ben Shun Hu; Ya Juan Chu; Yun Chang Tan; Xu Ji; Ke Chen; Xiang Min Ding; Aiqun Zhang; Fei Chen; Jia Hong Dong
Journal:  World J Surg       Date:  2013-03       Impact factor: 3.352

4.  Risk factors and classifications of hilar cholangiocarcinoma.

Authors:  Miguel Angel Suarez-Munoz; Jose Luis Fernandez-Aguilar; Belinda Sanchez-Perez; Jose Antonio Perez-Daga; Beatriz Garcia-Albiach; Ysabel Pulido-Roa; Naiara Marin-Camero; Julio Santoyo-Santoyo
Journal:  World J Gastrointest Oncol       Date:  2013-07-15

Review 5.  An update on liver surgery for cholangiocarcinoma.

Authors:  Karim Boudjema; Giovanni Battista Levi Sandri; Eveline Boucher; Tanguy Rohou; Michel Rayar; Laurent Sulpice
Journal:  Updates Surg       Date:  2013-10-02

Review 6.  Hilar cholangiocarcinoma: diagnosis, treatment options, and management.

Authors:  Kevin C Soares; Ihab Kamel; David P Cosgrove; Joseph M Herman; Timothy M Pawlik
Journal:  Hepatobiliary Surg Nutr       Date:  2014-02       Impact factor: 7.293

7.  The impact of changed strategies for patients with cholangiocarcinoma in this millenium.

Authors:  Per Lindnér; Magnus Rizell; Lo Hafström
Journal:  HPB Surg       Date:  2015-02-18

8.  GALNT14 genotype is associated with perineural invasion, lymph node metastasis and overall survival in resected cholangiocarcinoma.

Authors:  Kung-Hao Liang; Ta-Sen Yeh; Ren-Chin Wu; Chun-Nan Yeh; Chau-Ting Yeh
Journal:  Oncol Lett       Date:  2017-04-05       Impact factor: 2.967

9.  A New Surgical Procedure "Dumbbell-Form Resection" for Selected Hilar Cholangiocarcinomas With Severe Jaundice: Comparison With Hemihepatectomy.

Authors:  Shuguang Wang; Feng Tian; Xin Zhao; Dajiang Li; Yu He; Zhihua Li; Jian Chen
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.817

10.  An undifferentiated carcinoma at Klatskin-position with long-term complete remission after chemotherapy.

Authors:  Bruno Christian Köhler; Benjamin Goeppert; Nina Waldburger; Kai Schlamp; Peter Sauer; Dirk Jäger; Karl Heinz Weiss; Stephan Macher-Göppinger; Henning Schulze-Bergkamen; Peter Schirmacher; Christoph Springfeld
Journal:  Oncotarget       Date:  2018-04-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.